Large-scale testing (Phase 3)Study completedNCT01968460
What this trial is testing
Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
Who this might be right for
Parkinson's Disease
Pharma Two B Ltd. 149